Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Ultrasonic stimulation of the ear's vagus nerve in healthy adults

Official title: UltraSONIC Vagus Nerve Stimulation: Investigation U-VNS Effects on Physiological, Emotional and Cognitive Biomarkers

Run by University of Nottingham · NCT07283913 · Data updated 2026-11-12

This will test whether placing a painless ultrasound device on the ear can stimulate the vagus nerve in healthy adults.

More Healthy Adult Participants trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Nottingham
Academic / other
Locations2 sites (Nottingham, Nottinghamshire and 1 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMay 2026
Study endsMay 2026
Registry record updatedDecember 16, 2025
Trial IDNCT07283913 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18 or older who are not taking medications (except contraceptives), have no major neurological, psychiatric, cardiac, or metabolic disorders, and can follow study requirements like fasting and removing left-ear piercings.

Probably not a fit

People with diabetes, significant heart conditions or arrhythmias, high blood pressure, recent use of nervous-system–active drugs, or those seeking treatment for an existing medical condition are unlikely to benefit from participating in this healthy-volunteer protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will deliver non-invasive focused ultrasound to the auricular branch of the vagus nerve in healthy volunteers to see if this activates parasympathetic responses. Participants attend multiple visits with requirements such as removing left-ear piercings and fasting beforehand, while investigators record physiological and metabolic signals. The approach aims to provide a non-electrical alternative to implanted or transcutaneous electrical VNS, reducing risks associated with surgery or skin electrodes. Measurements likely include heart rate, breathing or other autonomic markers and metabolic signals such as glucose to determine acute effects of the stimulation.

Why it matters

Potential benefit: If successful, this could offer a non-invasive way to modulate the vagus nerve that might lead to safer, easier treatments for conditions currently treated with electrical or implanted VNS.

How similar studies have gone: Electrical and transcutaneous auricular VNS have shown therapeutic effects for epilepsy and some neuropsychiatric conditions, but ultrasonic auricular VNS in humans is novel with limited prior human data and mixed results for some indications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Participant is willing and able to give informed consent for participation in the study
* Not currently taking any medications (except the contraceptive pill)
* Aged 18 or over
* Good general health
* Able and willing to remove any piercings in the left ear
* Able to abstain from exercise and fast from food for 12 hours before the second and third visit

Exclusion Criteria

* Current or past diagnosis of a major neurological, neurosurgical, or psychiatric disorder (including self-reported depression)
* Inability to complete informed consent process
* Personal history of cardiac arrhythmia
* Diabetes
* High blood pressure (\>140 mmHg systolic and/or \>90 mmHg diastolic)
* Other significant medical condition (including cardiological disorders; specific details to be reviewed by the CI prior to inclusion)
* Use of medication or recreational drugs that affect the nervous system in the past 3 months
* Medication intake (such as beta-blockers, glucocorticoids, antidepressants, anti-inflammatory drugs) in the last 7 days - contraceptive medication in women is allowed
* Currently pregnant or breastfeeding
* Allergy to aquasonic gel or any of its components (propylene glycol, glycerin, isothiazolinones)
* Participation in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (required for all UoN FMHS UREC-approved studies)
* BMI \< 18 kg/m² or \> 30 kg/m²
* Excessive consumption of alcohol (\>2 alcoholic beverages/day) or tobacco (\>5 cigarettes/day)
* Previous experience with stress tests
* Known infection in the last 8 weeks

Where it's running

  • Neuromodulation Lab, Medical School, Queen's Medical Centre
    Nottingham, Nottinghamshire, United Kingdom
    Recruiting
  • University of Nottingham
    Nottingham, United Kingdom
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.